Latest News

Albemarle divests Ketjen control and Eurecat stakes in deals worth $660 Million

Albemarle announced on Monday that it would sell a 51 percent stake in its Ketjen refining catalyst solution business to KPS Capital Partners and its 50 percent interest in Eurecat to France's Axens SA in deals valued at approximately $660 million.

Albemarle said that proceeds from the sale of lithium would be used to reduce debt and for general corporate purposes. This is part of Albemarle's efforts to increase financial flexibility and focus on its lithium and bromine core units.

Albemarle has been attempting to reduce its portfolio in response to the recent drop in lithium prices, which has impacted earnings and cash flows.

Albemarle has said that once the transaction is closed in the first half 2026, it will retain a 49 percent minority stake in Ketjen, and the full ownership of the Performance Catalyst Solutions division, which includes the PCS plant located in Pasadena.

KPS, which has more than 19 billion dollars in assets under management, will use its manufacturing expertise to expand Ketjen’s global refining catalyst operations and increase profitability.

(source: Reuters)